Dr. Kriesel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-585-2031- Is this information wrong?
Education & Training
University of Utah HealthFellowship, Infectious Disease, 1991 - 1994- University of Utah HealthResidency, Internal Medicine, 1988 - 1991
Washington University in St. Louis School of MedicineClass of 1988
Certifications & Licensure
UT State Medical License 1989 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults Start of enrollment: 2013 Dec 01
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Comparison of Urinary Diversion in Patients With Prostatic Fistula to Those with Localized Radiation Injury After Radiotherapy for the Treatment of Prostate Cancer.Jeremy B Myers, Beatriz S Hernandez, Benjamin McCormick, Joemy Ramsay, John D Kriesel, Kevin J Hebert, Kiarad Fendereski> ;Urology. 2024 Jan 1
- 3 citationsSpinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteriaEmily Eckman, Jon D. Laman, Kael F. Fischer, Bert K. Lopansri, Tom B. Martins, Harry R. Hill, John D. Kriesel> ;Journal of Molecular Medicine. 2021 Jun 8
- 12 citationsSpectrum of Microbial Sequences and a Bacterial Cell Wall Antigen in Primary Demyelination Brain Specimens Obtained from Living Patients.John D. Kriesel, Preetida J. Bhetariya, Zheng-Ming Wang, David Renner, Cheryl A. Palmer, Kael F. Fischer> ;Scientific Reports. 2019 Feb 4
- Join now to see all
Journal Articles
- Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled TrialDavid I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases
Press Mentions
Drugmakers Racing to Create Effective Antiviral Pill for COVID-19 InfectionSeptember 27th, 2021
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine TrialApril 19th, 2017
MS Research Takes Center Stage at the Consortium of MS Centers’ Annual MeetingJune 15th, 2016- Join now to see all
Grant Support
- Deep Sequencing For The Detection Of Viral Sequences In Primary Progressive MultiNational Institute Of Neurological Disorders And Stroke2011
- STI And Respiratory Pathogen Testing In Nontraditional SettingsNational Institute Of Allergy And Infectious Diseases2009–2011
- A Novel Genetic Therapy For Herpes KeratitisNational Eye Institute2004–2006
- IL-6 In Herpes Simplex Virus Type 1 Ocular ReactivationNational Eye Institute1998–2002
- Randomized, Double Blind Study Of 1,25dihydroxy Vitamin D3 And Influenza VaccineNational Center For Research Resources1998–1999
- Randomized, Double Blind Study Of 1,25dihydroxy Vitamin D3 And Influenza Vaccin ENational Center For Research Resources1997
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
